Determination of traces of amorphous carvidilol content in carvedilol drug substance and drug product using modulated differential scanning colorimetry

Der Pharmacia Lettre

Volumn 3, Issue 4, 2011, Pages 1-12

  Raut, D M ^a   Sakharkar, D M ^a   Bodke, P S ^a   Mahajan, D T ^a  

^a C K Naidu Marg ^*  (India)

Author keywords

Amorphous phase; Drug product; Glass transition (Tg); Mdsc

Indexed keywords

CARVEDILOL;

AMORPHOUS CONTENT; AMORPHOUS PHASE; ARTICLE; CONTROLLED STUDY; CRYSTALLINE FORM; DIFFERENTIAL SCANNING CALORIMETRY; DRUG STRUCTURE; GLASS TRANSITION TEMPERATURE; HEAT CAPACITY; MODULATED DIFFERENTIAL SCANNING CALORIMETRY; PHYSICAL PARAMETERS; POWDER; POWDER X RAY DIFFRACTION; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; TABLET FORMULATION; THERMODYNAMICS; X RAY DIFFRACTION;

EID: 80052832496     PISSN: None     EISSN: 09755071     Source Type: Journal    
DOI: None     Document Type: Article

References (6)

1. Brittain HG, editor, Physical characterization of pharmaceutical solid, New York,1995 Morcel Dekker, Inc
2. N. Fagegaltier, A. Lamure, C. Lacabanne, A. Caron, H. Mifsud, and M. Bauer. 1997, J. Therm. Anal. 48:459-464.
3. M. Lappalainen et al, International Journal of Pharmaceutics, 2006, 307,150-155.
4. V.B. Pokharkar et al., Powder Technology 167 (2006) 20-25.
5. P. G. Royall, D. Q. M. Craig, and C. Doherty. Pharm. Res,1998, 15:1117-1121.
6. B. C. Hancock and G. Zografi, 1997, J Pharm. Sci. 86:1-12.